Certara (CERT) Sells Regulatory and Medical Writing Business for Up to $135M

On April 22, 2026, Certara, Inc. (NASDAQ:CERT) said it entered into a definitive statement to merchantability its regulatory and aesculapian penning concern to Veristat for up to $135 million. The woody is expected to adjacent successful the 2nd 4th of 2026, taxable to customary conditions. The divested portion generated $50 cardinal successful gross and $17 cardinal successful adjusted EBITDA successful 2025 and includes astir 220 employees. Certara said it plans to update its 2026 guidance aft the transaction closes.

On April 13, 2026, KeyBanc expert Scott Schoenhaus lowered his terms people connected Certara, Inc. (NASDAQ:CERT) to $8 from $10 portion maintaining an Overweight rating. The steadfast said the near-term setup remains mostly affirmative up of Q1 earnings, though it expects astir companies to reaffirm full-year guidance fixed macro uncertainty. KeyBanc added that healthcare utilization trends stay solid, supporting bundle spending, adjacent arsenic pharma integer advertizing conditions stay uneven.

In March, UBS lowered its terms people connected Certara, Inc. (NASDAQ:CERT) to $10 from $15 portion maintaining a Buy rating. The steadfast said fourth-quarter results and 2026 guidance challenged the bullish thesis, citing a services miss and slower bundle bookings. Despite that, UBS said Certara remains “uniquely positioned” successful model-informed cause development.

Certara, Inc. (NASDAQ:CERT) provides biosimulation bundle and services utilized successful cause discovery, objective development, regulatory submissions, and commercialization.

While we admit the imaginable of CERT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.